| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20020613 | HPV | ENSG00000136997.22 | protein_coding | MYC | Yes | No | 4609 | P01106 |
| TVIS20020614 | HPV | ENSG00000136997.22 | protein_coding | MYC | Yes | No | 4609 | P01106 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MYC |
|---|---|
| DrugBank ID | DB08813 |
| Drug Name | Nadroparin |
| Target ID | BE0004689 |
| UniProt ID | P01106 |
| Regulation Type | inhibitor |
| PubMed IDs | 19757196; 19261492 |
| Citations | Nagy Z, Turcsik V, Blasko G: The effect of LMWH (Nadroparin) on tumor progression. Pathol Oncol Res. 2009 Dec;15(4):689-92. doi: 10.1007/s12253-009-9204-7.@@Sustar V, Jansa R, Frank M, Hagerstrand H, Krzan M, Iglic A, Kralj-Iglic V: Suppression of membrane microvesiculation--a possible anticoagulant and anti-tumor progression effect of heparin. Blood Cells Mol Dis. 2009 May-Jun;42(3):223-7. doi: 10.1016/j.bcmd.2009.01.012. Epub 2009 Mar 3. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
